Microbot Medical Inc.

$1.74+0.58%(+$0.01)
TickerSpark Score
51/100
Mixed
60
Valuation
20
Profitability
60
Growth
84
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MBOT research report →

52-Week Range5% of range
Low $1.60
Current $1.74
High $4.67

Companywww.microbotmedical.com

Microbot Medical Inc. , a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio.

CEO
Harel Gadot
IPO
1992
Employees
20
HQ
Hingham, MA, US

Price Chart

-33.59% · this period
$4.50$3.06$1.62May 20Nov 18May 20

Valuation

Market Cap
$79.29M
P/E
-11.81
P/S
755.17
P/B
1.58
EV/EBITDA
-4.85
Div Yield
0.00%

Profitability

Gross Margin
-9.52%
Op Margin
-15278.10%
Net Margin
-9420.95%
ROE
-15.20%
ROIC
-21.39%

Growth & Income

Revenue
$0 · 0.00%
Net Income
$-13,142,000 · -14.85%
EPS
$-0.29 · 60.27%
Op Income
$-14,743,000
FCF YoY
-48.06%

Performance & Tape

52W High
$4.67
52W Low
$1.60
50D MA
$2.32
200D MA
$2.51
Beta
1.06
Avg Volume
1.86M

Get TickerSpark's AI analysis on MBOT

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Apr 1, 26Stockburger Aileen Ptuchaother10,000
Apr 1, 26Madden Martin J.other10,000
Apr 1, 26Wenderow Tal Baruchother10,000
Apr 1, 26Wilson David Jamesother10,000
Apr 1, 26Burell Scott Rother10,000
Apr 1, 26Laxminarain Prattipatiother10,000
Feb 18, 26Gadot Harelother480,000
Feb 18, 26Diaz-Cartelle Juanother105,000
Feb 18, 26Sharon Simonother105,000
Feb 18, 26Vaknin Rachelother105,000

Our MBOT Coverage

We haven't published any research on MBOT yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate MBOT Report →

Similar Companies